Search Results - "MacDermed, Dhara M"

Primary Tumor Necrosis Predicts Distant Control in Locally Advanced Soft-Tissue Sarcomas After Preoperative Concurrent Chemoradiotherapy by MacDermed, Dhara M., M.D, Miller, Luke L., B.S, Peabody, Terrance D., M.D, Simon, Michael A., M.D, Luu, Hue H., M.D, Haydon, Rex C., M.D., Ph.D, Montag, Anthony G., M.D, Undevia, Samir D., M.D, Connell, Philip P., M.D

“…Purpose Various neoadjuvant approaches have been evaluated for the treatment of locally advanced soft-tissue sarcomas. This retrospective study describes a…”
Get full text

STAT1-dependent expression of energy metabolic pathways links tumour growth and radioresistance to the Warburg effect by Pitroda, Sean P, Wakim, Bassam T, Sood, Ravi F, Beveridge, Mara G, Beckett, Michael A, MacDermed, Dhara M, Weichselbaum, Ralph R, Khodarev, Nikolai N

“…The Signal Transducer and Activator of Transcription 1 (STAT1) has traditionally been regarded as a transmitter of interferon signaling and a pro-apoptotic…”
Get full text

MUC1-associated proliferation signature predicts outcomes in lung adenocarcinoma patients by MacDermed, Dhara M, Khodarev, Nikolai N, Pitroda, Sean P, Edwards, Darrin C, Pelizzari, Charles A, Huang, Lei, Kufe, Donald W, Weichselbaum, Ralph R

“…MUC1 protein is highly expressed in lung cancer. The cytoplasmic domain of MUC1 (MUC1-CD) induces tumorigenesis and resistance to DNA-damaging agents. We…”
Get full text

The Clinical Utility of a 7-Gene Biosignature on Radiation Therapy Decision Making in Patients with Ductal Carcinoma In Situ Following Breast-Conserving Surgery: An Updated Analysis of the DCISionRT® PREDICT Study by Shah, Chirag, Whitworth, Pat, Vicini, Frank A., Narod, Steven, Gerber, Naamit, Jhawar, Sachin R., King, Tari A., Mittendorf, Elizabeth A., Willey, Shawna C., Rabinovich, Rachel, Gold, Linsey, Brown, Eric, Patel, Anushka, Vargo, John, Barry, Parul N., Rock, David, Friedman, Neil, Bedi, Gauri, Templeton, Sandra, Brown, Sheree, Gabordi, Robert, Riley, Lee, Lee, Lucy, Baron, Paul, Majithia, Lonika, Mirabeau-Beale, Kristina L., Reid, Vincent J., Hirsch, Arica, Hwang, Catherine, Pellicane, James, Maganini, Robert, Khan, Sadia, MacDermed, Dhara M., Small, William, Mittal, Karuna, Borgen, Patrick, Cox, Charles, Shivers, Steven C., Bremer, Troy

“…Background Breast-conserving surgery (BCS) followed by adjuvant radiotherapy (RT) is a standard treatment for ductal carcinoma in situ (DCIS). A low-risk…”
Get full text

ASO Visual Abstract: The Clinical Utility of a 7-Gene Biosignature on Radiation Therapy Decision Making in Patients with Ductal Carcinoma In Situ Following Breast-Conserving Surgery: An Updated Analysis of the DCISionRT® PREDICT Study by Shah, Chirag, Whitworth, Pat, Vicini, Frank A., Narod, Steven, Gerber, Naamit, Jhawar, Sachin R., King, Tari A., Mittendorf, Elizabeth A., Willey, Shawna C., Rabinovich, Rachel, Gold, Linsey, Brown, Eric, Patel, Anushka, Vargo, John, Barry, Parul N., Rock, David, Friedman, Neil, Bedi, Gauri, Templeton, Sandra, Brown, Sheree, Gabordi, Robert, Riley, Lee, Lee, Lucy, Baron, Paul, Majithia, Lonika, Mirabeau-Beale, Kristina L., Reid, Vincent J., Hirsch, Arica, Hwang, Catherine, Pellicane, James, Maganini, Robert, Khan, Sadia, MacDermed, Dhara M., Small, William, Mittal, Karuna, Borgen, Patrick, Cox, Charles, Shivers, Steven C., Bremer, Troy

Get full text

A rationale for the targeted treatment of oligometastases with radiotherapy by MacDermed, Dhara M., Weichselbaum, Ralph R., Salama, Joseph K.

“…An oligometastatic state has been proposed wherein patients with metastases limited in number and location may benefit from local therapy directed at all known…”
Get full text

MUC1-Induced Transcriptional Programs Associated with Tumorigenesis Predict Outcome in Breast and Lung Cancer by KHODAREV, Nikolai N, PITRODA, Sean P, BECKETT, Michael A, MACDERMED, Dhara M, LEI HUANG, KUFE, Donald W, WEICHSELBAUM, Ralph R

“…The Mucin 1 (MUC1) oncoprotein is aberrantly overexpressed in diverse human malignancies including breast and lung cancer. Although MUC1 modulates the activity…”
Get full text

Diverse perspectives on the current state of genomic medicine: has the revolution begun? by Macdermed, Dhara M, Uribe-Bruce, Liliana

“…A report on the Future of Genomic Medicine IV meeting held in La Jolla, California, USA, 3-4 March 2011…”
Get full text

Therapeutic radiation dose delivered to the low axilla during whole breast radiation therapy in the prone position: Implications for targeting the undissected axilla by MacDermed, Dhara M., Houtman, Kristen M., Thang, Sandy H., Allen, Pamela K., Caudle, Abigail S., Gainer, Sarah M., Hunt, Kelly K., Perkins, George H., Shaitelman, Simona F., Smith, Benjamin D., Strom, Eric A., Tereffe, Welela, Woodward, Wendy A., Buchholz, Thomas A., Hoffman, Karen E.

“…One interpretation of the American College of Surgeons Oncology Group Z0011 trial is that whole breast radiation therapy, known to treat a portion of the low…”
Get full text

Abstract 5251: CXCL14 as a functional determinant in a novel model of inflammatory, triple negative breast cancer progression by MacDermed, Dhara M., Lorger, Mihaela, O'Sullivan, Deirdre, Ritland, Melissa, Forsyth, Jane, Torkamani, Ali, Murray, Sarah, Steele, Julie, Kroener, Joan, Smider, Vaughn V., Felding-Habermann, Brunhilde

“…Abstract CXCL14 (BRAK) is a cytokine implicated in inflammatory responses, but its contribution to cancer is largely unknown. Recent studies in clinical breast…”
Get full text

Primary Tumor Necrosis Predicts Distant Control in Locally Advanced Soft Tissue Sarcomas Following Preoperative Concurrent Chemoradiotherapy by MacDermed, Dhara M., Miller, Luke L., Peabody, Terrance D., Simon, Michael A., Luu, Hue H., Haydon, Rex C., Montag, Anthony G., Undevia, Samir D., Connell, Philip P.

Get full text

Cytokine CXCL14 As a Functional Determinant In a Novel Model Of Inflammatory, Triple Negative Breast Cancer Progression by MacDermed, Dhara M

“…A novel model of triple-negative, inflammatory breast cancer enabled an investigation into the biology of breast cancer progression. The model consists of…”
Get full text

Concurrent hormone and radiation therapy in patients with breast cancer: what is the rationale? by Chargari, Cyrus, MD, Toillon, Robert Alain, PhD, MacDermed, Dhara, MD, Castadot, Pierre, MD, Magné, Nicolas, Dr

“…Summary Endocrine therapy is often given together with postoperative radiotherapy in patients with breast cancer and positive hormone-receptor status. However,…”
Get full text